Introduction Pfizer Inc is a New York based pharmaceutical company. The company is the largest research based pharmaceutical group in sales around the world. It should be known that the company is the world’s largest pharmaceutical company with a market share of 6.7% (Pfizer 2010, p. 23). Source: Duke University, 2010 As a matter of fact, Pfizer has been invested in mergers and acquisitions in order to expand its market share in both the established and emerging markets (Pfizer 2010, p. 13). This condition has been occasioned by the presence of more than 200 major companies in the pharmaceutical industry currently. Furthermore, the Company faces stiff competition from other pharmaceutical companies such as GlaxoSmithKline and Novartis, which are projected to earn revenues of more than 61 billion dollars by the end of 2010 (Pfizer 2010, p. 16). Pfizer Inc has largest market share in the USA pharmaceutical industry. In this case, the company is the leading player in that market. In 2007, the company had a market share of 13.7% (Pfizer 2010, p. 13). In accordance with the statistics offered, Pfizer Inc is expected to get 50,009 million dollars in revenues (Pfizer 2010, p. 17), this is why the company is still considered as the largest market player in comparison to other organizations such as GlaxoSmithKline or Novartis. The company has a wide range of productions that have continued to entice the market. These productions include Lipitor, Diflucan, Viagra, Celebrex, Zithromax and others. Apart from this, the company had the largest number of blockbuster products in 2009 (Pfizer 2010, p. 19). In this case, it had 14 products including 5 products that were inherited through mergers and acquisitions. Pfizer pharmaceutical company has a total number of 27 registered products. Additionally, the company produces various generic products, which are manufactured and sold in different markets in the world through effective marketing strategies. For instance, in the United States, the company sells its products through the greenstone subsidiary. Moreover, Pfizer has various licensing deals with other companies such as Aurobindo. As a result, Pfizer has gained access to other markets such as the oral solid generic products through the licensing deals (Pfizer 2010, p. 18). Furthermore, the company has animal health products such as A180, Rimadyl, Excenel, and many more. In addition to the achievements demonstrated, the company has a wide financial asset base and trades its shares on the New York stock exchange market. In the 2009, the company had revenues of more than $ 50 billion. In addition, it has an operating income of 411.9 billion (Pfizer 2010, p. 37). Wholesomely, the company’s total asserts are valued at about $213 billion in 2009. Balance Sheet – 4/4/2010   * Current Assets $49,916,000,000   * Current Liabilities $25,924,000,000   * Total Debt $38,281,000,000   * Total Assets $195,113,000,000   * Intangible Assets $64,480,000,000   * Goodwill $42,648,000,000   * Total Liabilities $105,454,000,000   * Outstanding Shares 8,066,130,000   * Source: Modern Graham, 2010 The company’s earnings per share have been increasing as time goes by. In 2010, its earnings per share are expected to be $ 1.48.